Orthofix Int'l (OFIX) Tops Q2 EPS by 5c, Beats on Revenues; Raises FY!& Sales Outlook Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Orthofix International (OFIX) PT Raised to $55 at Jefferies Following 2Q Beat
August 8, 2017 8:29 AM EDTJefferies raised its price target on Orthofix International (NASDAQ: OFIX) to $55.00 (from $50.00) while maintaining a Buy rating following the company's 2Q. Sales of $108.9mn handily beat consensus estimates of $102.9mn as everything except Extremities is doing well.
The sales guidance range... More
